Merck & Co., Inc. (MRK) Management on 4th Annual Evercore ISI HealthCONx Virtual Conference (Transcript)Seeking Alpha • 12/01/21
After high hopes for Merck's COVID-19 pill, Wall Street now expects a ‘tepid' authorizationMarket Watch • 12/01/21
Merck's Pneumococcal 15-valent Conjugate Vaccine Under Priority FDA Review For Use In KidsBenzinga • 12/01/21
U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for Merck's VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) for Use in Infants and ChildrenBusiness Wire • 12/01/21
Merck's new Covid pill gets the US regulatory green light - but only justProactive Investors • 12/01/21
Merck and Ridgeback Statement on Positive FDA Advisory Committee Vote for Investigational Oral Antiviral Molnupiravir for Treatment of Mild to Moderate COVID-19 in High Risk AdultsBusiness Wire • 11/30/21
An FDA expert panel narrowly supports the first COVID-19 pill but suggests restrictions on its use driven by safety concernsBusiness Insider • 11/30/21
FDA advisory panel narrowly endorses Merck's oral Covid treatment pill, despite reduced efficacy and safety questionsCNBC • 11/30/21
FDA Panel Recommends Merck's Covid-19 Antiviral Pill For Emergency Use AuthorizationForbes • 11/30/21
FDA advisers to vote Tuesday on Merck's COVID-19 pill even as interest has wanedMarket Watch • 11/30/21